Patient-derived H3 K27M and H3WT glioma neurosphere lines were established at Dana-Farber Cancer Institute (BT869/BT869Luci; available from the Dana-Farber Cancer Institute Center for Patient Derived Models) and Hospital Sant Joan de Deu Barcelona (HSJD-DIPG007, HSJD-GBM001) as previously described (36 (
link)–38 (
link)). Neurosphere lines SU-DIPGXIIILuci, SU-DIPGXIIP*Luci, SU-DIPGXXV, SU-pcGBM2, and SU-DIPG48 were a gift from Michelle Monje at Stanford University, Stanford, California, USA. H3 K27M glioma cells were grown as neurospheres in tumor stem media base (38 (
link)) supplemented with
B27 minus vitamin A (Thermo Fisher Scientific), human growth factors (
EGF,
FGF,
PDGF-AA,
PDGF-BB from Shenandoah Biotechnology), and
heparin (Stemcell Technologies) in ultra-low-attachment flasks. Indicated cell models expressing luciferase were generated as previously described (39 (
link)). Neurosphere cultures were dissociated for passaging using
Accutase cell detachment solution (Stemcell Technologies) for 3–5 minutes at 37°C. All neurosphere models were authenticated by high-resolution STR profiling (Molecular Diagnostics Core, Dana-Farber Cancer Institute). Whole-exome or whole-genome sequencing was conducted on neurosphere models to obtain copy number alterations.
So J., Mabe N.W., Englinger B., Chow K.H., Moyer S.M., Yerrum S., Trissal M.C., Marques J.G., Kwon J.J., Shim B., Pal S., Panditharatna E., Quinn T., Schaefer D.A., Jeong D., Mayhew D.L., Hwang J., Beroukhim R., Ligon K.L., Stegmaier K., Filbin M.G, & Hahn W.C. (2022). VRK1 as a synthetic lethal target in VRK2 promoter–methylated cancers of the nervous system. JCI Insight, 7(19), e158755.